Mr. Patrone has advised on a number of high-profile and cross-border M&A and SPAC transactions, including:
- MyoKardia, Inc. in connection with its $13.1 billion sale to Bristol-Myers Squibb Company
- Twilio Inc. in connection with its acquisition of SendGrid, Inc. in an all-stock transaction valued at approximately $3 billion
- Foundation Medicine, Inc. in connection with its merger with Roche at an enterprise valuation of $5.3 billion
- Immatics N.V. in connection with its business combination with SPAC Arya Sciences Acquisition Corp. in a transaction valued at approximately $1 billion
- PTC Inc. in connection with its strategic partnership with Rockwell Automation, Inc. and securing a $1 billion equity investment
- Evergreen Coast Capital in connection with its $1.6 billion acquisition of Gigamon Inc.*
- Hewlett Packard Enterprise Company in connection with the $7 billion spin-off and merger of its Enterprise Services business with Computer Sciences Corporation to form DXC Technology Company*
- Hologic, Inc. in connection with the sale of its blood screening business for $1.85 billion to Grifols S.A.*
- Diamond Resorts International, Inc. in connection with its $2.2 billion sale to Apollo Management*
- Shire plc in connection with its abandoned $54.8 billion sale to AbbVie Inc.*
- Bertelsmann SE & Co. KGaA and Random House in connection with the merger of Random House with Penguin Publishing House*
- Dalian Wanda Group in connection with its $2.6 billion acquisition of AMC Entertainment Holdings, Inc.*
- Roche in connection with certain acquisitions*
- Warner Chilcott plc in connection with certain acquisitions*
*Denotes experience prior to joining Goodwin.
